Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6994)
All Articles published online
|
Publishing Process of This Article
|
Jun 22, 2016 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bou Khalil R, Khoury E, Koussa S. Linking multiple pathogenic pathways in Alzheimer’s disease. World J Psychiatr 2016; 6(2): 208-214 [PMID: 27354962 DOI: 10.5498/wjp.v6.i2.208] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v6/i2/208.htm |
| Number | Citing Articles |
| 1 |
Sanghamitra Bandyopadhyay. Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction. Frontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.653334
|
| 2 |
Joseph D'Arrigo. Nanotherapy for Early Dementia: Targeting Senile Endothelium. SSRN Electronic Journal 2017; doi: 10.2139/ssrn.3031579
|
| 3 |
Joseph D'Arrigo. Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile Endothelium. SSRN Electronic Journal 2017; doi: 10.2139/ssrn.3041744
|
| 4 |
Qing‑Fang Gu, Jie‑Zhong Yu, Hao Wu, Yan‑Hua Li, Chun-Yun Liu, Ling Feng, Guang‑Xian Zhang, Bao‑Guo Xiao, Cun‑Gen Ma. Therapeutic effect of Rho kinase inhibitor FSD‑C10 in a mouse model of Alzheimer's disease. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6701
|
| 5 |
Joseph S. D’Arrigo. Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier. Biomimetics 2018; 3(1): 4 doi: 10.3390/biomimetics3010004
|
| 6 |
Feng Zhang, Long Niu, Song Li, Weidong Le. Pathological Impacts of Chronic Hypoxia on Alzheimer’s Disease. ACS Chemical Neuroscience 2019; 10(2): 902 doi: 10.1021/acschemneuro.8b00442
|
| 7 |
Rakesh Agarwal, Phillip J. Tully, Rajiv Mahajan. Cognitive Function in Atrial Fibrillation: A Narrative Review of Evidence and Mechanisms. Heart and Mind 2024; 8(2): 100 doi: 10.4103/hm.HM-D-23-00075
|
| 8 |
Dahu Li, Lijun Zhang, Xin Huang, Lili Liu, Yunling He, Lun Xu, Yiyao Zhang, Tong Zhao, Liying Wu, Yongqi Zhao, Kuiwu Wu, Yan Wu, Ming Fan, Lingling Zhu. WIP1 Phosphatase Plays a Critical Neuroprotective Role in Brain Injury Induced by High-Altitude Hypoxic Inflammation. Neuroscience Bulletin 2017; 33(3): 292 doi: 10.1007/s12264-016-0095-9
|
| 9 |
Joseph S. D’Arrigo. Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting. Medical Sciences 2017; 5(4): 29 doi: 10.3390/medsci5040029
|
| 10 |
Joseph S. D’Arrigo. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia. American Journal of Alzheimer's Disease & Other Dementias® 2020; 35 doi: 10.1177/1533317520976761
|
| 11 |
Nicole Yu, Mazhar Pasha, John Jia En Chua. Redox changes and cellular senescence in Alzheimer's disease. Redox Biology 2024; 70: 103048 doi: 10.1016/j.redox.2024.103048
|
| 12 |
Joseph S. D'Arrigo. Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium. Advances in Colloid and Interface Science 2018; 251: 44 doi: 10.1016/j.cis.2017.12.002
|
| 13 |
Sarah L. Morgan, Pourya Naderi, Katjuša Koler, Yered Pita-Juarez, Dmitry Prokopenko, Ioannis S. Vlachos, Rudolph E. Tanzi, Lars Bertram, Winston A. Hide. Most Pathways Can Be Related to the Pathogenesis of Alzheimer’s Disease. Frontiers in Aging Neuroscience 2022; 14 doi: 10.3389/fnagi.2022.846902
|
| 14 |
Fabiola Sârbu, Mihaela Lungu, Violeta Oprea, Aurelia Romila. Early depressive manifestations in patients with dementia caused by Alzheimer's disease. Experimental and Therapeutic Medicine 2023; 27(2) doi: 10.3892/etm.2023.12344
|
| 15 |
Gabriela Aguilera, Ana Laura Colín-González, Edgar Rangel-López, Anahí Chavarría, Abel Santamaría. Redox Signaling, Neuroinflammation, and Neurodegeneration. Antioxidants & Redox Signaling 2018; 28(18): 1626 doi: 10.1089/ars.2017.7099
|
| 16 |
Joanna Dietzel, Karl Georg Haeusler, Matthias Endres. Does atrial fibrillation cause cognitive decline and dementia?. EP Europace 2018; 20(3): 408 doi: 10.1093/europace/eux031
|
| 17 |
Veronica Tisato, Giovanni Zuliani, Marco Vigliano, Giovanna Longo, Eugenia Franchini, Paola Secchiero, Giorgio Zauli, Elvezia Maria Paraboschi, Ajay Vikram Singh, Maria Luisa Serino, Beatrice Ortolani, Amedeo Zurlo, Cristina Bosi, Antonio Greco, Davide Seripa, Rosanna Asselta, Donato Gemmati, Stephen D. Ginsberg. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases. PLOS ONE 2018; 13(3): e0193867 doi: 10.1371/journal.pone.0193867
|
| 18 |
Rashmi Kadam, Muskan Gupta, Orly Lazarov, Bellur S Prabhakar. Brain-immune interactions: implication for cognitive impairments in Alzheimer's disease and autoimmune disorders. Journal of Leukocyte Biology 2024; 116(6): 1269 doi: 10.1093/jleuko/qiae134
|
| 19 |
Joseph D’Arrigo. Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades. Biomimetics 2020; 5(1): 11 doi: 10.3390/biomimetics5010011
|